McClarren Financial Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
McClarren Financial Advisors's PFE Position: Q2 2025 in Review
McClarren Financial Advisors sold out of Pfizer (PFE) in Q2 2025, closing a stake of 4,977 shares — an estimated $134K sold.
McClarren Financial Advisors first reported a position in PFE in Q4 2020 and held it in 16 quarters. The position peaked at $279K in Q4 2021. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.
- McClarren Financial Advisors reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
- McClarren Financial Advisors sold 4,977 Pfizer shares in Q2 2025, an estimated $134K.
- McClarren Financial Advisors first reported a position in Pfizer in Q4 2020 and held it in 16 quarters.
- McClarren Financial Advisors's Pfizer position peaked at $279K in Q4 2021.
- 2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.
Based on McClarren Financial Advisors's 13F filing for Q2 2025, filed 7 Aug 2025.